HeXun Biosciences Co., Ltd.
Update:2026/01/07
Industries
Main Industry
Biotechnology
Main Product/Service
HeXun’s offerings include allogeneic mesenchymal‑stem‑cell drugs, contract development and manufacturing services (CDMO/CMO), sterile‑filling services, cell and derivative testing and consulting, and a laboratory information‑management system — supported
Founded Year
2019
Unified Business No.
50924393
Status
Active
Number of Employees
46
Total Paid-in
Capital
460,000,000 (NT$)
Location of Company
Taiwan
, Taoyuan City
Exit Status
Emerging Stock Exchange(2023)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
HeXun Biosciences Co., Ltd., founded in 2019, is a biotechnology company dedicated to stem‑cell research and therapy, aiming to transform cutting‑edge cellular technologies into high‑quality medical solutions under its core philosophy “LIVE LONG, HEALTHY